Kidney international | 2019

IdeS in anti-glomerular basement membrane disease: Is this the new deal?

 
 

Abstract


IdeS, a proteinase from Streptococcus pyogenes, cleaves IgG antibodies with a unique specificity. Herein, the authors report the dramatic efficacy of IdeS on the levels of anti-glomerular membrane autoantibodies in 3 three patients with Goodpasture disease refractory to standard therapy. The levels of anti-glomerular membrane autoantibodies were reduced to near-zero levels within 2 hours of the injection. However, all patients ultimately required permanent hemodialysis as a result of the late intervention in the course of the disease.

Volume 96 5
Pages \n 1068-1070\n
DOI 10.1016/j.kint.2019.08.017
Language English
Journal Kidney international

Full Text